Association between CYP2C19 genotype and proguanil oxidative polymorphism

British Journal of Clinical Pharmacology

Volumn 43, Issue 6, 1997, Pages 659-660

  Coller, J K ^a   Somogyi, A A ^a   Bochner, F ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

CYP2C19; Intrinsic clearance; Metabolic ratio; Mutant alleles; Proguanil

Indexed keywords

PROGUANIL;

ARTICLE; DRUG METABOLISM; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030738072     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00596.x     Document Type: Article

References (10)

1. de Morais SMF, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of S-mephenytoin metabolism in Japanese. Mol Pharmacol 1994; 46: 594-598.
2. Helsby NA, Ward SA, Edwards CJ, Howells RE, Breckenridge AM. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. Br J Clin Pharmacol 1990; 30: 593-598.
3. Ward SA, Watkins WM, Mberu E, et al. Intersubject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. Br J Clin Pharmacol 1989; 27: 781-787.
4. Birkett DJ, Rees D, Andersson T, Gonzalez FJ, Miners JO, Veronese ME. In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase. BrJ Clin Pharmacol 1994; 37: 413-420.
5. Somogyi AA, Reinhard HA, Bochner F. Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism. Br J Clin Pharmacol 1996; 41: 175-179.
6. de Morais SMF, Goldstein JA, Xie H-G, et al. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther 1995; 58: 404-411.
7. de Morais SMF, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Golstein JA. The major defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 1994; 269: 15419-15422.
8. Daly AK, Brockmoller J, Broly F, et al. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996; 6: 193-201.
9. Watkins WM, Mberu E, Nevill CG, Ward SA, Breckenridge AM, Koech DK. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Trans Roy Soc Trop Med Hyg 1990; 84: 492-495.
10. Edstein MD, Shanks GD, Teja-Isavadharm P, Rieckmann KH, Webster HK. Oxidative activation of proguanil and daspone acetylation in Thai soldiers. Br J Clin Pharmacol 1994; 37: 67-70.